IRCT20180523039800N1招募中2 期
Comparison and evaluation of the effect of budesonide nebulizer with oral systemic steroids on the amount of peak expiratory flow rate (PEFR) change using peak flowmetry of patients with exacerbated chronic obstructive pulmonary disease (COPD) referred to the emergency department; Non-inferiority Double-Blind Randomized Clinical Trial
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 70 years（—）
- 性别
- All
入选标准
- •Patients with exacerbated COPD following respiratory infection
- •15-70 years old
- •Disease severity of moderate to severe based on GOLD scoring
排除标准
- •Exacerbated COPD with a cause other than respiratory infection
- •History of asthma, allergic rhinitis or atopy
- •History of systemic corticosteroids more than 1500 micrograms/ day over the past month
- •Patients with decreased consciousness
- •Known psychological disorder and inability to cooperate in the study
研究者
相似试验
已完成
4 期
A randomized comparison of the effects of budesonide spray and K-Y gel as an endotracheal tube cuff lubricant on the incidence of postoperative sore throatPostoperative sore throat (POST) is a frequent complication following tracheal intubation under general anesthesia.postoperative sore throat, cough, hoarseness, budesonide spray, intubationTCTR20220113001/A100
招募中
3 期
Effect of budesonide nebulizer on reducing BPDIRCT20230823059227N1Karaj University of Medical Sciences180
招募中
3 期
Comparison of Benson relaxation technique and supplemental oxygen therapy and their combination on anxiety and chemotherapy-induced nausea and vomiting in patients with gastric cancerIRCT20180808040742N3Oroumia University of Medical Sciences100
招募中
2 期
A randomized, comparative study of Budesonide/formoterol versus Fluticasone/Salmeterol in COPD with asthma patients to improve oxidative stress and inflammatory mediatorsCOPD with asthmaJPRN-UMIN000005204Jikei University Hospital30
已完成
Unknown
Budesonide tablet bioequivalenceBioequivalence study in healthy volunteers.IRCT20130313012810N23Tasnim pharmaceutical Company24